Segment Results (Additional Selected Financial Information For Reportable Segments) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting Information [Line Items]
Depreciation expense	$ 13,418	$ 11,862	$ 38,739	$ 38,865
Amortization expense	70,806	45,136	194,273	143,776
U.S. Branded Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense	4,319	4,059	12,730	14,774
Amortization expense	18,590	18,743	57,052	64,870
U.S. Generic Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense	4,514	3,402	12,392	9,841
Amortization expense	24,818	10,881	63,588	32,643
Devices [Member]
Segment Reporting Information [Line Items]
Depreciation expense	1,776	2,221	6,304	7,876
Amortization expense	15,438	15,512	46,475	46,263
International Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense	718	0	1,209	0
Amortization expense	11,960	0	27,158	0
Corporate unallocated [Member]
Segment Reporting Information [Line Items]
Depreciation expense	$ 2,091	$ 2,180	$ 6,104	$ 6,374